Arrowstreet Capital’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-110,110
Closed -$9.11M 1784
2024
Q2
$9.11M Sell
110,110
-57,387
-34% -$4.75M 0.01% 662
2024
Q1
$14.3M Buy
167,497
+9,480
+6% +$809K 0.01% 584
2023
Q4
$13.5M Sell
158,017
-77,187
-33% -$6.6M 0.01% 492
2023
Q3
$21.1M Sell
235,204
-435,981
-65% -$39.1M 0.03% 381
2023
Q2
$57.1M Buy
671,185
+10,137
+2% +$863K 0.07% 225
2023
Q1
$54.7M Buy
661,048
+33,730
+5% +$2.79M 0.07% 257
2022
Q4
$49.3M Buy
627,318
+454,459
+263% +$35.7M 0.07% 239
2022
Q3
$12.8M Buy
172,859
+139,181
+413% +$10.3M 0.02% 469
2022
Q2
$2.2M Buy
+33,678
New +$2.2M ﹤0.01% 757
2021
Q2
Sell
-39,300
Closed -$4.36M 2019
2021
Q1
$4.36M Buy
39,300
+36,972
+1,588% +$4.1M 0.01% 1235
2020
Q4
$276K Sell
2,328
-161,874
-99% -$19.2M ﹤0.01% 2136
2020
Q3
$14.3M Sell
164,202
-42,731
-21% -$3.73M 0.02% 695
2020
Q2
$18.5M Buy
+206,933
New +$18.5M 0.03% 529
2019
Q3
Sell
-17,873
Closed -$2.15M 1613
2019
Q2
$2.15M Sell
17,873
-6,727
-27% -$810K ﹤0.01% 887
2019
Q1
$2.15M Buy
+24,600
New +$2.15M 0.01% 1084
2018
Q4
Sell
-187,848
Closed -$21.5M 1394
2018
Q3
$21.5M Sell
187,848
-251,434
-57% -$28.8M 0.05% 277
2018
Q2
$39.4M Buy
439,282
+355,412
+424% +$31.9M 0.1% 200
2018
Q1
$6.14M Buy
+83,870
New +$6.14M 0.01% 536
2017
Q4
Sell
-154,861
Closed -$6.95M 1306
2017
Q3
$6.95M Buy
154,861
+5
+0% +$224 0.02% 435
2017
Q2
$6.12M Buy
+154,856
New +$6.12M 0.02% 436
2016
Q2
Sell
-10,800
Closed -$378K 1401
2016
Q1
$378K Sell
10,800
-114,553
-91% -$4.01M ﹤0.01% 1172
2015
Q4
$4.04M Buy
125,353
+32,053
+34% +$1.03M 0.02% 614
2015
Q3
$3.02M Buy
93,300
+85,000
+1,024% +$2.75M 0.01% 659
2015
Q2
$343K Buy
+8,300
New +$343K ﹤0.01% 1037
2014
Q4
Sell
-20,308
Closed -$709K 1268
2014
Q3
$709K Buy
+20,308
New +$709K ﹤0.01% 780
2014
Q2
Sell
-111,544
Closed -$3.64M 1052
2014
Q1
$3.64M Buy
+111,544
New +$3.64M 0.02% 509